FinancialContent is the trusted provider of stock market information to the media industry.
June 26, 2012 at 17:57 PM EDT
Lexicon Reports Positive Results
Lexicon Pharmaceuticals Inc. (Nasdaq: LXRX) reported positive results from a midstage clinical trial of its diabetes treatment LX4211 lifting the stock price 31 cents to close at $2.26.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here